SUPPLEMENTARY MATERIALS AND METHODS

Methylation status of CD70 promotor region
Pyrosequencing
Cells were treated with vehicle or 7 µM CDDP for 24 h. DNA was isolated 24 h post-treatment using the 'GenElute™ Blood Genomic DNA Kit' (Qiagen, Venlo, The Netherlands). Bisulphite conversion was achieved using Epitect Fast DNA bisulphite kit (Qiagen), following the instructions of the manufacturer. Bisulphite-converted DNA was then used as a template for PCR. The primer sequences and PCR conditions are summarized in Supplementary Table 2 . Amplification was carried out using the PyroMark PCR kit (Qiagen), following the instructions of the manufacturer. Next, biotin-labeled PCR products were captured with Streptavidin Sepharose beads (GE healthcare, UK) and made single stranded using a pyrosequencing vacuum prep Tool (Qiagen).
Pyrosequencing was performed on a PyroMark Q24 instrument (Qiagen) and cytosine methylation was quantified using the Pyromark Q24 software.
Cytotoxicity assays IncuCyte
TM
Real-time measurement of ADCC was performed using the incuCyte ™ (Essen Bioscience, Hertfordshire, United Kingdom). NCI-H1975 cells were seeded at 5 × 10 3 cells/well, incubated overnight and exposed to 7 µM CDDP (IC20-value A549 cell line) or vehicle for 24 h. One day after treatment, medium was aspirated and replaced with medium containing the IncuCyte ™ Caspase-3/7 Apoptosis Reagent (Essen Bioscience). Cells were treated with ARGX-110 (arGEN-x BVBA, Zwijnaarde, Gent, 0.5 µM) or isotype control (I5029, Sigma-Aldrich, Diegem, Belgium, 0.5µM) in combination with effector (E) NK cells (E:T=5:1) and cell-death was assessed for 18 h.
